Cargando…
How I treat AML incorporating the updated classifications and guidelines
The European LeukemiaNet recently revised both the clinical (2022) and measurable residual disease testing (2021) guidelines for acute myeloid leukemia (AML). The updated World Health Organization and International Consensus Classification for myeloid neoplasms were also published in 2022. Together,...
Autores principales: | El Chaer, Firas, Hourigan, Christopher S., Zeidan, Amer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447497/ https://www.ncbi.nlm.nih.gov/pubmed/36758209 http://dx.doi.org/10.1182/blood.2022017808 |
Ejemplares similares
-
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
por: El Chaer, Firas, et al.
Publicado: (2022) -
How we treat Merkel cell carcinoma: within and beyond current guidelines
por: Park, Song Y, et al.
Publicado: (2021) -
How I Treat Acute and Persistent Sickle Cell Pain
por: Ballas, Samir K.
Publicado: (2020) -
How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023) -
How I treat older patients with DLBCL in the frontline setting
por: Lugtenburg, Pieternella J., et al.
Publicado: (2023)